| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/03/2006 | WO2006080582A1 Agent for control of function of antigen-presenting cell |
| 08/03/2006 | WO2006080498A1 Tablets containing ornithine hydrochloride |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060172927 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1685090A1 Androgen receptor modulators |
| 08/02/2006 | EP1684786A1 Enhancement of growth hormone levels with a dipeptidyl peptidase iv inhibitor and a growth hormone secretagogue |
| 08/02/2006 | EP1684740A1 Phenylpropanoic derivatives and compositions containing same, which stimulate libido and the associated physiological mechanisms |
| 08/02/2006 | EP1684727A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 08/02/2006 | EP1272196B1 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | CN1812961A Propionamide derivatives useful as androgen receptor modulators |
| 08/02/2006 | CN1812956A Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267103C Applicaton of montmorillonite inpreparing medicine |
| 08/01/2006 | US7084177 Antidiabetic agents |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | CA2360024C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 07/27/2006 | WO2006008316A3 Selective inhibitors of human corticosteroid syntheses |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167047 Tetrahydorquinoline derivatives and their use as fsh receptor modulators |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166973 4-(7-Cyclopropylmethyl-6-oxo-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazin-5-yl)-benzonitrile; cytochrome P450 inhibitors; hypokalemia, hypertension, congestive heart failure, renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post myocardial infarction, coronary heart disease |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166871 Medical compositions containing ghrelin |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165683 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 07/26/2006 | EP1682122A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1349578B1 Medicinal association of a biguanine (metformin) and arginine |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | CN1809373A Synthetic peptide combinations and methods of producing same |
| 07/26/2006 | CN1809369A Extract from plant of japanese parsley family and process for producing the same |
| 07/25/2006 | US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy |
| 07/25/2006 | US7081261 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health |
| 07/25/2006 | CA2289209C Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof |
| 07/25/2006 | CA2235430C Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 07/20/2006 | WO2006076317A2 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | WO2006076277A1 Compositions and methods for increasing the bioavailability of pulmonarily administered insulin |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074957A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | WO2006031715A3 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
| 07/20/2006 | WO2005105148A3 Liquid growth hormone formulation |
| 07/20/2006 | WO2005075021A3 Chemically-modified human growth hormone receptor antagonist conjugates |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160889 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160745 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 07/20/2006 | US20060159770 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 07/20/2006 | CA2601343A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | CA2594340A1 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681304A2 Recombinant fusion proteins of growth hormone and serum albumin |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1399142B1 Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | CN1805751A Methods of managing the symptoms of premenstrual syndrome. |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078487 Polynucleotides encoding the zebrafish PTH1R (parthyroid hormone like protein) receptor |
| 07/18/2006 | US7078394 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen as above and a progestogen equivalent to 90 mu g per day of norgestimate. |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/13/2006 | WO2006073147A1 Remedial agent for fat toxicity |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072647A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 07/13/2006 | WO2006072600A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 07/13/2006 | WO2006072599A2 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/13/2006 | WO2006072467A1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | US20060154982 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases such as cancer, psoriasis, arteriosclerosis or is at risk of restenosis of the coronary arteries after vascular surgery |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |